Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Pride 2024: How can pharma leaders make a difference?
Hear from four pharma leaders on the benefits to employees and patients of workplaces that promote inclusivity for the LGBTQ+ community.
Read more
Taking a bet on blockchain
GOLD explores what the pharmaceutical industry’s future might look like with the adoption of blockchain technology within its key functions.
Bridging the digital health divide
Technology has redefined the exchange of health information. Find out how the pharma industry can help patients build confidence about digital health tools.
Nurturing home-grown innovation in Europe
Europe is a front runner for pharmaceutical research and thought leadership Find out in what measure this is translating into home-grown innovation.
Reacting to supply chain risks
The pharmaceutical supply chain is vulnerable to adverse events, and the pandemic has served as a reminder of how these networks can be tested. The industry has learned tough lessons from COVID-19 that must be translated into modernisation and improvements
The return of the vaccines
The pandemic revived all areas of vaccine development. Read more about the effect of Covid-19 on investment, development and commercialisation of vaccines.
Pursuing a pathway of preventative medicine
A world without illness or disease sounds like a far-off fantasy, but some players in the pharmaceutical industry are investigating how to transform this vision into a reality.
Pharma in China
As China enters the year of the tiger – a symbol of strength and bravery – GOLD journeys to this powerhouse nation to explore how it has become the second largest pharmaceutical market in the world
The uphill recruitment battle
Recruitment for pharma is not an easy task, especially when the goal is to appeal to the younger generation. Read the article and find out more.
Loading posts...
« Previous
1
…
15
16
17
18
19
…
30
Next »